Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Profiling breast cancer by array CGH.

Donna G Albertson1

  • 1Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143-0808, USA. albertson@cc.ucsf.edu

Breast Cancer Research and Treatment
|May 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MMP1 and PRSS23 induce PAR<sub>2</sub> biased agonism in painful oral cancers.

Communications biology·2026
Same author

TRPV4 activation in Schwann cells mediates mechanically induced pain of oral cancer.

Frontiers in pain research (Lausanne, Switzerland)·2025
Same author

PAR<sub>2</sub> on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451.

Biomaterials·2024
Same author

Measurement of the Association of Pain with Clinical Characteristics in Oral Cancer Patients at Diagnosis and Prior to Cancer Treatment.

Journal of pain research·2024
Same author

Calcitonin Related Polypeptide Alpha Mediates Oral Cancer Pain.

Cells·2023
Same author

Oral cancer patients experience mechanical and chemical sensitivity at the site of the cancer.

BMC cancer·2022
Same journal

Comments on: Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer.

Breast cancer research and treatment·2026
Same journal

Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy.

Breast cancer research and treatment·2026
Same journal

Discrimination, spectrum, and clinical utility: ICG lymphography drainage time in axillary staging.

Breast cancer research and treatment·2026
Same journal

Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen.

Breast cancer research and treatment·2026
Same journal

Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

Breast cancer research and treatment·2026
Same journal

Subjective socioeconomic status moderates the relationship between objective neighborhood disadvantage and quality of life in middle- and older-aged women with breast cancer.

Breast cancer research and treatment·2026
See all related articles

This review explores DNA copy number variations in breast tumors using microarray-based comparative genomic hybridization (array CGH). It discusses the technology, its applications in breast cancer analysis, and the origins of copy number changes.

Area of Science:

  • Oncology
  • Genetics
  • Genomics

Background:

  • Breast tumors exhibit diverse genomic alterations.
  • Understanding these changes is crucial for diagnosis and treatment.
  • DNA copy number variations are a significant category of these alterations.

Purpose of the Study:

  • To review DNA copy number variations in breast tumors.
  • To focus on microarray-based comparative genomic hybridization (array CGH) technology.
  • To discuss the applications and underlying mechanisms of copy number changes in breast cancer.

Main Methods:

  • Review of existing literature on array CGH.
  • Analysis of array CGH capabilities for genomic variation detection.
  • Discussion of initial applications in breast cancer research.

Related Experiment Videos

Main Results:

  • Array CGH is a powerful technology for measuring DNA copy number variations.
  • Initial studies reveal specific patterns of copy number changes in breast tumors.
  • These changes are linked to potential mechanisms of tumor development.

Conclusions:

  • Array CGH provides valuable insights into breast tumor genomics.
  • Further research is needed to fully elucidate the mechanisms driving copy number alterations.
  • This technology holds promise for advancing breast cancer research and diagnostics.